Dianthus Therapeutics, Inc. /DE/ ($DNTH)
Filing Information
| Accession Number | 0001778623-26-000007 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 11, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
60,000
Total Value
$2,566,432.71
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP, General Counsel and Sec. | Common Stock | โ | Aug 7, 2026 | Exercise/Conversion | 3,833 | $17.88 | $68,534.04 | 3,833 | Direct | โ | View Details | |
SVP, General Counsel and Sec. | Common Stock | โ | Aug 7, 2026 | Sale | 3,217 | $110.61 | $355,832.37 | 616 | Direct | โ | View Details | |
SVP, General Counsel and Sec. | Common Stock | โ | Aug 7, 2026 | Sale | 616 | $111.18 | $68,486.88 | 0 | Direct | โ | View Details | |
SVP, General Counsel and Sec. | Common Stock | โ | Aug 10, 2026 | Exercise/Conversion | 16,167 | $17.88 | $289,065.96 | 16,167 | Direct | โ | View Details | |
SVP, General Counsel and Sec. | Common Stock | โ | Aug 10, 2026 | Sale | 16,167 | $110.38 | $1,784,513.46 | 0 | Direct | โ | View Details | |
SVP, General Counsel and Sec. | Stock Option (Right to Buy) | Derivative | Aug 7, 2026 | Exercise/Conversion | 3,833 | $0.00 | $0.00 | 76,167 | Direct | โ | View Details | |
SVP, General Counsel and Sec. | Stock Option (Right to Buy) | Derivative | Aug 10, 2026 | Exercise/Conversion | 16,167 | $0.00 | $0.00 | 60,000 | Direct | โ | View Details |